Stu was Vice President, Oncology Business Unit Head at Gilead Sciences, and Vice President, Worldwide Commercialization at Bristol-Myers Squibb. Stu Dorman joined Ideaya Biosciences in 2024.
Stu Dorman is currently
Create your alert
to follow the career of Stu Dorman.
Stu Dorman has a Master of Business Administration from Stanford Business School.
They have also studied at Stanford Business School :
Find more alumni from Stanford Business School
Do you need to know more about Stu Dorman? More results.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.